Hospital Del Mar

Futó vizsgálatok

• Még nem toboroz

  A Study of Ivonescimab Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC

  2026-526300-67-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Toboroz

  Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  2025-523288-39-00· 2. fázis· Mediar Therapeutics Inc.· Forrás

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study of DS-3939a in Participants With Solid Tumors

  NCT07739966· 1/2. fázis· Daiichi Sankyo· Forrás

• Még nem toboroz

  Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

  2025-524969-24-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Még nem toboroz

  A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation

  NCT07814417· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tumour location (right-PTL) - ARIEL-ENGIC 04 EU trial

  2025-521209-42-00· 4. fázis· Fondazione GONO G.I.· Forrás

• Toboroz

  A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)

  NCT07465757· 2. fázis· Puma Biotechnology, Inc.· Forrás

• Még nem toboroz

  Extracorporeal Carbon Dioxide Removal Plus Noninvasive Ventilation in Patients With COPD Not Eligible for Intubation

  NCT07785375· Hospital del Mar Research Institute (IMIM)· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  2025-524335-39-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· AstraZeneca· Forrás

• Toboroz

  Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  NCT07686263· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis

  NCT07720375· 2. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  Virtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple Sclerosis

  NCT07310862· Clarity Health Technologies, Inc· Forrás

• Toboroz

  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic)

  NCT07864207· 1/2. fázis· IDP Discovery Pharma S.L.· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.

  2025-522076-85-00· 2. fázis· AstraZeneca AB· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Phase 1/2 multicenter, two-arms, open-label, dose-escalation study of IDP-121 in combination with chemotherapy in patients with relapsed small cell lung cancer (SCLC) (MYCrocytic)

  2025-521902-17-00· 1/2. fázis· Idp Discovery Pharma S.L.· Forrás

• Toboroz

  Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  NCT07489066· 2. fázis· Pfizer· Forrás

• Fut, nem toboroz

  A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small cell lung cancer.

  2023-503298-39-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A clinical trial to provide continued access to remibrutinib (LOU064) for people who are benefiting from it in a previous remibrutinib trial

  2025-524078-40-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.

  NCT07333066· 3. fázis· Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD· Forrás

• Toboroz

  INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

  NCT07429266· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)

  2025-524002-16-00· 3. fázis· Ferrer Internacional S.A.· Forrás

• Toboroz

  A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  NCT07513376· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.

  NCT07593820· 1. fázis· Vall d'Hebron Institute of Oncology· Forrás

• Toboroz

  Phase 2 Study of iadademstat for the treatment of patients with essential thrombocythemia resistant/intolerant to hydroxyurea.

  2025-523864-19-00· 2. fázis· Oryzon Genomics S.A.· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  NCT07285655· 3. fázis· Liquidia Technologies, Inc.· Forrás

• Toboroz

  A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

  NCT07365995· 3. fázis· BioNTech SE· Forrás

• Toboroz

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

  2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás

• Toboroz

  Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia

  NCT07394153· 2. fázis· Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas· Forrás

• Toboroz

  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  NCT07472517· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  NCT07361497· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  NCT07456033· 3. fázis· GlaxoSmithKline· Forrás

• Toboroz

  A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  NCT07361510· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  NCT07421700· 1/2. fázis· Pfizer· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

  NCT07282574· 2. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  Treatment for Ph-negative ALL for Adults up to 65 Years

  NCT07443592· PETHEMA Foundation· Forrás

• Toboroz

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  NCT07223814· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Még nem toboroz

  SAVE trial

  2025-523709-13-00· 3. fázis· Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau· Forrás

Showing 50 of 337.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák29 toboroz
• Vastagbélrák16 toboroz
• Prosztatarák14 toboroz
• Áttétes emlőrák11 toboroz
• Gyomor- és nyelőcsőrák10 toboroz
• Hólyagrák8 toboroz
• Stroke (szélütés)7 toboroz
• Sclerosis multiplex (SM)6 toboroz
• Szívelégtelenség6 toboroz
• Tripla negatív emlőrák6 toboroz
• Akut mieloid leukémia (AML)5 toboroz
• Chronic spontaneous urticaria5 toboroz
• Krónikus limfoid leukémia (CLL)5 toboroz
• Bronchiectasis4 toboroz
• Hasnyálmirigyrák4 toboroz
• Mieloproliferatív neopláziák4 toboroz
• Pitvarfibrilláció4 toboroz
• Amiotrófiás laterálszklerózis (ALS)3 toboroz
• Deep vein thrombosis and pulmonary embolism3 toboroz
• Depresszió3 toboroz
• Immune thrombocytopenia (ITP)3 toboroz
• Koszorúér-betegség3 toboroz
• Magas vérnyomás3 toboroz
• Neuroendokrin daganatok3 toboroz
• Pulmonális artériás hipertónia3 toboroz
• Skizofrénia3 toboroz
• Vesedaganat3 toboroz
• Aortic stenosis2 toboroz
• Atópiás dermatitisz (ekcéma)2 toboroz
• Cisztás fibrózis2 toboroz
• Epilepszia2 toboroz
• Gyermekkori daganatok2 toboroz
• Hidradenitis suppurativa2 toboroz
• HIV-fertőzés2 toboroz
• IgA-nefropátia2 toboroz
• Liver cirrhosis2 toboroz
• Méhtestrák2 toboroz
• Osteoarthritis2 toboroz
• Petefészekrák2 toboroz
• Rheumatoid arthritis2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Alzheimer-kór1 toboroz
• Asztma1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Down syndrome1 toboroz
• Elhízás1 toboroz
• Endometriózis1 toboroz
• Fej-nyaki daganatok1 toboroz
• Follikuláris limfóma1 toboroz
• Glioblasztóma1 toboroz
• Hodgkin-limfóma1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Lupus (SLE)1 toboroz
• Pajzsmirigyrák1 toboroz
• Postpartum depression1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Tuberkulózis1 toboroz
• Vitiligo1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures

  2025-524038-24-00· 3. fázis· Praxis Precision Medicines Inc.· Forrás

• Fut, nem toboroz

  An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps

  NCT07424144· 3. fázis· Sanofi· Forrás

• Fut, nem toboroz

  Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

  NCT06931405· 2. fázis· Blueprint Medicines Corporation· Forrás

• Lezárult

  Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria.

  2024-518786-10-01· 2. fázis· Evommune Inc.· Forrás

• Toboroz

  Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures

  2024-514499-42-00· 3. fázis· Neuraxpharm Pharmaceuticals S.L.· Forrás

• Lezárult

  Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis

  NCT07105163· Procare Health Iberia S.L.· Forrás

• Lezárult

  An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients with Focal Onset or Primary Generalized Tonic-Clonic Seizures

  2024-517061-16-01· 2. fázis· Praxis Precision Medicines Inc.· Forrás

• Lezárult

  A RANDOMIZED PHASE I, DOUBLE-BLIND, PARALLEL, COMPARATIVE ASSESSMENT OF PHARMACOKINETICS, SAFETY, PHARMACODYNAMICS, AND IMMUNOGENICITY OF LT-01 (AN OMALIZUMAB BIOSIMILAR CANDIDATE [TEST]) LYOPHYLIZED POWDER FOR SUBCUTANEOUS INJECTION VERSUS EU-APPROVED XOLAIR® LYOPHYLIZED POWDER FOR SUBCUTANEOUS INJECTION (REFERENCE) IN HEALTHY SUBJETCS: CIMA STUDY.

  2023-505908-28-00· 1. fázis· Laboratorios Liomont S.A. de C.V.· Forrás

• Lezárult

  Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated ROS1-Positive Non-small Cell Lung Cancer (NSCLC)

  NCT05828303· 1. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Fut, nem toboroz

  A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

  NCT06593522· 2. fázis· Amgen· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

  NCT06544733· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Lezárult

  A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)

  2024-514559-13-00· 2/3. fázis· Praxis Precision Medicines Inc.· Forrás

• Lezárult

  Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHINE

  NCT06425159· 2/3. fázis· Biohaven Therapeutics Ltd.· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

  NCT06614192· 2. fázis· AbbVie· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Fut, nem toboroz

  A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

  NCT06284954· 2. fázis· argenx· Forrás

• Lezárult

  A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

  NCT06588738· 3. fázis· Alumis Inc· Forrás

• Lezárult

  Study to assess the safety, pharmacokinetics and efficacy of HMPL-523 in patients with Immune Thrombocytopenia

  2023-508819-23-00· 1. fázis· Hutchmed Ltd.· Forrás

• Lezárult

  Impact of Perioperative Hyperoxia on Cancer Recurrence and Mortality After Elective Colorectal Cancer Surgery

  NCT06989346· Parc de Salut Mar· Forrás

• Lezárult

  A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction

  NCT06195930· 2. fázis· Bayer· Forrás

• Lezárult

  A Phase 2 Trial of BDC-1001 as Single Agent and in Combination with Pertuzumab in Subjects with Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Previously Treated with Trastuzumab Deruxtecan

  NCT05954143· 2. fázis· Bolt Biotherapeutics Inc.· Forrás

• Lezárult

  Comparison of three short rifamycin-based regimens to treat latent tuberculosis in patients with end-stage kidney disease.

  2023-506432-32-00· 4. fázis· Bellvitge University Hospital· Forrás

• Visszavonták

  The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

  NCT06291415· 1. fázis· Hutchmed· Forrás

• Lezárult

  A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

  NCT06323928· 2. fázis· H. Lundbeck A/S· Forrás

• Lezárult

  A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

  2023-506092-10-00· 2. fázis· Ascendis Pharma Oncology Division A/S· Forrás

• Lezárult

  A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

  NCT06168409· 3. fázis· AstraZeneca· Forrás

• Lezárult

  This is a clinical trial (study), to be conducted at multiple clinical sites, of an oral study drug (EP262) that will be investigated in adult participants with Chronic Spontaneous Urticaria (CSU) to assess if it is effective and safe.

  2023-504799-94-00· 2. fázis· Escient Pharmaceuticals Inc.· Forrás

• Lezárult

  VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

  NCT06214052· 2. fázis· ViiV Healthcare· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06212999· 3. fázis· Incyte Corporation· Forrás

• Leállították

  Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

  NCT06268574· 2. fázis· Ryvu Therapeutics SA· Forrás

• Lezárult

  A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia with or without NPM1 Mutation (RIVER-52)

  2023-505910-10-00· 2. fázis· Ryvu Therapeutics S.A.· Forrás

• Lezárult

  A randomized, multi-centre, double-blind, phase II clinical trial of dose finding of Montelukast in patients with erosive osteoarthritis of the hands. HOME study.

  2023-506137-30-00· 2. fázis· Farmalider S.A.· Forrás

• Lezárult

  Metabolomics and Bariatric Surgery in Patients With Metabolically Unhealthy Obesity

  NCT06297928· Parc de Salut Mar· Forrás

• Lezárult

  Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

  NCT06017609· 2. fázis· Shionogi Inc.· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

  NCT06034743· 3. fázis· AstraZeneca· Forrás

• Lezárult

  GRemubamab ErAdication Trial (GREAT-2)

  2022-502494-41-00· 2. fázis· NHS Tayside· Forrás

• Lezárult

  A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants

  NCT05963984· 2. fázis· Carrick Therapeutics Limited· Forrás

• Leállították

  A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer

  NCT05983367· 2. fázis· Inspirna, Inc.· Forrás

• Lezárult

  Phase II trial of trastuzumab deruxtecan in first-line treatment HER2-positive locally advanced or metastatic breast cancer (MBC) patients considered resistant to trastuzumab + pertuzumab + taxane due to early relapse. “TRANSCENDER Study”

  NCT05744375· 2. fázis· Grupo Espanol De Investigacion En Cancer De Mama· Forrás

• Lezárult

  A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT05848011· 2. fázis· MacroGenics· Forrás

• Leállították

  Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

  NCT06077773· 2. fázis· Escient Pharmaceuticals, Inc· Forrás

• Lezárult

  BPL-003 Efficacy and Safety in Treatment Resistant Depression

  NCT05870540· 2. fázis· Beckley Psytech Limited· Forrás

• Toboroz

  A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors

  NCT05642780· 2. fázis· Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.· Forrás

• Lezárult

  A study to investigate response to ompenaclid combined with FOLFIRI plus bevacizumab in patients with advanced or metastatic colorectal cancer

  2023-503356-27-00· 2. fázis· Inspirna Inc.· Forrás

• Lezárult

  Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

  NCT05635734· 1/2. fázis· Cantex Pharmaceuticals· Forrás

• Lezárult

  Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  2022-502196-31-00· 2/3. fázis· Kartos Therapeutics Inc.· Forrás

• Lezárult

  TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma

  NCT03529448· 1/2. fázis· Grupo Español de Investigación en Neurooncología· Forrás

• Lezárult

  A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

  NCT05798520· 2. fázis· Biogen· Forrás

• Lezárult

  Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

  NCT05834738· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)

  NCT05757570· 1/2. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás

Showing 50 of 186.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Bronchiectasis10 munka · 5 vizsgálat
• Hidradenitis suppurativa8 munka · 9 vizsgálat
• Mieloproliferatív neopláziák8 munka · 9 vizsgálat
• Mielodiszplasztikus szindróma (MDS)7 munka · 4 vizsgálat
• Chronic spontaneous urticaria6 munka · 15 vizsgálat
• Immune thrombocytopenia (ITP)5 munka · 10 vizsgálat
• Follikuláris limfóma5 munka · 6 vizsgálat
• Uterine fibroids4 munka · 0 vizsgálat